Impact of COVID-19 on Melanoma Therapeutics Market

As the world grapples with one of its greatest health pandemic, the economic and social disruption has affected millions of enterprises. The revenues have gone down in the year 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operation and strategy will sustain and beat the competition. Stratview Research throws light on in-depth insights related to rapid alterations in the key players in each industry, growth and decline due to COVID-19, etc. The researchers at Stratview Research are regularly connecting with the clients and other key players of almost all the industries, regarding the impact of COVID-19 on their businesses.

Key Players involve in this research are:

• AstraZeneca (UK),

• Amgen, Inc. (The U.S),

• F. Hoffman-La Roche Ltd. (Switzerland),

• Bristol-Myers Squibb Company (The U.S),

• Novartis AG (Switzerland),

• Merck & Co., Inc. (The U.S),

• Daiichi Sankyo Company Limited (Japan), and

• AB Sciences (France).

Growth drivers and Market Value:

This report, from Stratview Research Melanoma Therapeutics Market value and growth drivers over the trend period of 2021-26. According to the report -

The Melanoma Therapeutics Market is expected to grow from USD 4.8 billion in 2020 to USD 9.1 billion by 2026 at a CAGR of over 11.3% during the forecast period.

Segment Analysis:

Therapy Trends

Based on therapy, the global melanoma therapeutics market has been categorized into chemotherapy, immunotherapy, targeted therapy, and radiation therapy.

• Among these, the chemotherapy segment held a substantial market share in 2020.

• This can be ascribed to its high adoption rate in the past few years owing to the growing incidence of cancer, especially skin cancers.

• Chemotherapy includes a wide range of therapeutics that involve protein-related synthetically derived products.

Regional Trends

By region, the North America market witnessed the highest market share in 2020 and is projected to register a robust CAGR during the review period.

• This is majorly attributed to increasing incidence of melanoma and other skin cancers in the region.

• In 2013, as per CDC, over 71,943 people were affected by melanoma.

• According to the American Cancer Society, this number is projected to go up to 87,100 cases in 2017.

• These statistics highlight the need for drugs that help in the management of melanoma over the following years.

Wish to know more assumptions about the study? Click here:

https://www.stratviewresearch.com/1643/melanoma-therapeutics-market.html

Competitive Analysis: Understanding your rivalry is critical to your success. This section includes an analysis of your key competitors, their products/services, their differentiators, and market shares, etc.

Target Market and Audience: Identifying and prioritizing specific target markets is another key part of any industry, where research is crucial. Stratview Research’s report will help you find more about the demographics and buying behaviours of your potential customers.

Key Considerations for Market Forecast:

-          Impact of lockdown, supply chain disruptions.

-          Pre and post-COVID-19 market estimates

-          Geographical Breakdown: Regional level analysis of the market, currently covering North America, Europe, China & Japan

Impact of COVID-19 on the Global Market

The Melanoma Therapeutics report compiled by Stratview Research offers in-depth study of market opportunities and market impact that are stirred due to the COVID-19 pandemic. The detailed research report focuses upon the direct and indirect impact of COVID-19 with new product launches, M&As, supply chain overview, government regulations, strategies adopted by related market, etc.